RPTOR and neoplasm: It has been reported that high‐frequency mutations of RAPTOR (13%) and TP53 (30%) are intimately associated with HAS malignant transformation and progression.26 Moreover, subcellular localization of RAPTOR might admonish an idiosyncratic phenotype of tumor cells.